Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-033261
Filing Date
2022-06-16
Accepted
2022-06-16 12:57:25
Documents
1
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4.html 4  
1 PRIMARY DOCUMENT doc4.xml 4 32378
  Complete submission text file 0001213900-22-033261.txt   33682
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
Tomsche David Scott (Reporting) CIK: 0001384044 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 221019957